[Primary hyperoxaluria with endstage renal failure in an infant]

Célia S Macedo1, Eneida M Yoshida, Rosa Marlene Viero

  • 1Dep de Pediatria, Universidade Estadual Paulista, Botucatu, SP. pediatri@fmb.unesp.br

Jornal De Pediatria
|December 3, 2003
PubMed

Insights

Primary hyperoxaluria is a rare condition causing endstage renal failure in infants. Early diagnosis is crucial, as this case highlights the need for considering it in infants with kidney failure.

Area of Science:

  • Nephrology
  • Pediatrics
  • Metabolic Disorders

Context:

  • Primary hyperoxaluria is a rare genetic disorder characterized by excessive oxalate production.
  • Infants with primary hyperoxaluria often present with severe kidney disease, including endstage renal failure.
  • The diagnosis can be challenging due to nonspecific initial symptoms.

Purpose:

  • To present a case of infant endstage renal failure due to primary hyperoxaluria.
  • To emphasize the importance of considering primary hyperoxaluria in the differential diagnosis of infantile kidney failure.
  • To highlight the diagnostic findings and initial management in this rare condition.

Summary:

  • A 6-month-old infant presented with endstage renal failure, vomiting, and failure to thrive.
  • Diagnostic workup revealed high urinary oxalate levels, calcium oxalate crystals on renal biopsy, osteopathy, and retinopathy.
  • The infant was treated with peritoneal dialysis and pyridoxine.

Impact:

  • This case underscores the critical need for early recognition and diagnosis of primary hyperoxaluria in infants with renal failure.
  • Prompt diagnosis and management can potentially alter the disease course and improve outcomes.
  • Increased awareness among clinicians can lead to earlier interventions for this rare but severe condition.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...